Frailty Assessment in Vascular Hot Clinic Setting - Feasibility and Prognostic Value
FAVOUR
1 other identifier
observational
150
1 country
1
Brief Summary
A single-centre prospective study of feasibility assessing the suitability of introducing routine frailty screening in a controlled, and reproducible, outpatient department setting for Vascular Surgery patients. This study will also perform head-to-head comparisons of the prognostic value of five frailty assessment tools, selected based on the previous demonstration of their popularity and familiarity within the speciality, their designs being based on different theories of frailty and that some are endorsed by local healthcare police. Inter-user variability (patient self assessment and clinician assessment will also be compared).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2023
CompletedFirst Submitted
Initial submission to the registry
September 1, 2023
CompletedFirst Posted
Study publicly available on registry
September 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedSeptember 15, 2023
September 1, 2023
4 months
September 1, 2023
September 14, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Feasibility of implementing routine frailty assessment in a vascular clinic setting
Proportion of patients recruited (Number of recruited patients/\[number of patients attending clinic - number of ineligible patients\]).
During participant recruitment, over up to 4 months.
Frailty assessment completion time
Time taken to complete assessments (presented in seconds). The less time taken, the better.
During participant recruitment, over up to 4 months.
Frailty assessment completion rates
Proportion of assessments with non-completion. Calculated by: number of incomplete frailty assessments/total number of recruited patients, the lower the value the better.
During participant recruitment, over up to 4 months.
Secondary Outcomes (9)
Assessing the prognostic value of selected frailty assessment tools (Home time - all patients)
30-days and 1 year from recruitment/clinic attendance
Assessing the prognostic value of selected frailty assessment tools (Mortality - all patients)
30-days and 1 year from recruitment/clinic attendance
Assessing the peri-operative prognostic value of selected frailty assessment tools (Mortality)
30-days and 1 year from primary intervention offered following recruitment to study.
Assessing the peri-operative prognostic value of selected frailty assessment tools (Complications)
30-days and 1 year from primary intervention offered following recruitment to study.
Assessing the peri-operative prognostic value of selected frailty assessment tools (Length of stay)
30-days and 1 year from primary intervention offered following recruitment to study.
- +4 more secondary outcomes
Study Arms (1)
Vascular 'hot' clinic.
All adults (aged \> 17 years) referred to an urgent-referral, consultant-led, Vascular Surgery outpatient clinic, who have capacity, will be eligible for inclusion in this study.
Interventions
Eligibility Criteria
All referrals to vascular hot clinic are eligible for inclusion, preferentially recruiting new referrals. As frailty is related to age, but does not directly correlate with it, no age cut-off has been defined. As this is primarily a study of feasibility, patients will not be excluded/included based on presenting symptom or diagnosed pathology. A proxy (relative/friend/carer), if present, will also be invited to participate and assist with frailty assessments of the patients, where suitable. The participation of the proxy is dependent on the patient providing written consent agreeing to their participation, as well as the proxy being eligible to participate, according to the same inclusion/exclusion criteria set out for patients below.
You may qualify if:
- Adults (aged 18 years or older)
- Attending Vascular Hot Clinic
You may not qualify if:
- Lacking capacity to provide informed consent
- Parent clinical team feel frailty assessment not suitable
- Non-English speaker without qualified translator present
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Elizabeth University Hospital
Glasgow, Lanarkshire, G51 4TF, United Kingdom
Related Publications (1)
Welsh SA, Hussey K, Brittenden J, Orr DJ, Quinn T. Frailty Assessment in Vascular OUtpatients Review (FAVOUR) protocol: single-centre prospective cohort study comparing feasibility and prognostic value of commonly used frailty assessment tools. BMJ Open. 2023 Dec 9;13(12):e079387. doi: 10.1136/bmjopen-2023-079387.
PMID: 38070914DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Quinn
University of Glasgow
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
September 1, 2023
First Posted
September 15, 2023
Study Start
March 15, 2023
Primary Completion
July 17, 2023
Study Completion
November 1, 2024
Last Updated
September 15, 2023
Record last verified: 2023-09